Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CMNP.JK Stock Summary
Top 10 Correlated ETFs
CMNP.JK
In the News
CMNP.JK Financial details
Company Rating
Buy
Market Cap
8698.93B
Income
1109.37B
Revenue
4453.06B
Book val./share
2090.02
Cash/share
109.24
Dividend
-
Dividend %
-
Employees
5
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
7.35
Forward P/E
-
PEG
1.46
P/S
1.83
P/B
0.72
P/C
14.46
P/FCF
-1.91
Quick Ratio
0.14
Current Ratio
0.49
Debt / Equity
0.42
LT Debt / Equity
0.37
-
-
EPS (TTM)
204.27
EPS next Y
-
EPS next Q
-
EPS this Y
23.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-2.1%
Revenue last 5Y
3.16%
Revenue Q/Q
-98.86%
EPS Q/Q
80.14%
-
-
-
-
SMA20
4.46%
SMA50
4.59%
SMA100
4.46%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
10%
ROC
0.09%
Gross Margin
41%
Oper. Margin
37%
Profit Margin
25%
Payout
-
Shs Outstand
5.44B
Shs Float
4.93B
-
-
-
-
Target Price
-
52W Range
1480.0-1850.0
52W High
-14.59%
52W Low
+6.76%
RSI
55
Rel Volume
0.36
Avg Volume
55.99K
Volume
19.9K
Perf Week
1.61%
Perf Month
4.29%
Perf Quarter
2.93%
Perf Half Y
0.64%
-
-
-
-
Beta
0.179
-
-
Volatility
19.06%, 35.57%
Prev Close
-1.86%
Price
1580
Change
-3.36%
CMNP.JK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 944.31 | 871.85 | 683.98 | 817.01 | 821.34 | |
Net income per share | 186.8 | 187.49 | 118.41 | 135.8 | 168.27 | |
Operating cash flow per share | 160.63 | 109.54 | 86.81 | 248.39 | 168.27 | |
Free cash flow per share | -163.23 | -138.89 | -104.09 | 33.35 | -444.67 | |
Cash per share | 691.5 | 731.41 | 748.45 | 229.38 | 184.26 | |
Book value per share | 1.57K | 1.76K | 2.37K | 1.77K | 1.92K | |
Tangible book value per share | 17.21 | -9 | 268.16 | -94.2 | -513.2 | |
Share holders equity per share | 1.57K | 1.76K | 2.37K | 1.77K | 1.92K | |
Interest debt per share | 1.12K | 1.57K | 1.46K | 328.86 | 544.57 | |
Market cap | 5179.47B | 7506.18B | 5828.15B | 10863B | 11901.61B | |
Enterprise value | 6072.15B | 10568.68B | 7215.09B | 11364.43B | 14411.83B | |
P/E ratio | 6.85 | 9.89 | 13.01 | 14.73 | 13.01 | |
Price to sales ratio | 1.36 | 2.13 | 2.25 | 2.45 | 2.67 | |
POCF ratio | 7.97 | 16.93 | 17.74 | 8.05 | 13.01 | |
PFCF ratio | -7.84 | -13.36 | -14.79 | 59.97 | -4.93 | |
P/B Ratio | 0.81 | 1.05 | 0.65 | 1.13 | 1.14 | |
PTB ratio | 0.81 | 1.05 | 0.65 | 1.13 | 1.14 | |
EV to sales | 1.59 | 3 | 2.79 | 2.56 | 3.23 | |
Enterprise value over EBITDA | 5.67 | 8.55 | 8.29 | 10.15 | 11.46 | |
EV to operating cash flow | 9.34 | 23.84 | 21.96 | 8.42 | 15.76 | |
EV to free cash flow | -9.19 | -18.8 | -18.32 | 62.74 | -5.96 | |
Earnings yield | 0.15 | 0.1 | 0.08 | 0.07 | 0.08 | |
Free cash flow yield | -0.13 | -0.07 | -0.07 | 0.02 | -0.2 | |
Debt to equity | 0.69 | 0.84 | 0.58 | 0.16 | 0.27 | |
Debt to assets | 0.33 | 0.39 | 0.31 | 0.1 | 0.16 | |
Net debt to EBITDA | 0.83 | 2.48 | 1.59 | 0.45 | 2 | |
Current ratio | 3 | 1.55 | 2.27 | 0.66 | 0.47 | |
Interest coverage | 5.37 | 3 | 2.07 | 4.95 | 13.49 | |
Income quality | 0.86 | 0.58 | 0.73 | 1.83 | 1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.52 | 0.51 | 0.53 | 0.72 | 0.79 | |
Capex to operating cash flow | -2.02 | -2.27 | -2.2 | -0.87 | -3.64 | |
Capex to revenue | -0.34 | -0.28 | -0.28 | -0.26 | -0.75 | |
Capex to depreciation | 0 | -8.19 | -6.68 | -10.01 | -19.3 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.57K | 2.73K | 2.51K | 2.33K | 2.7K | |
ROIC | 0.07 | 0.07 | 0.04 | 0.07 | 0.08 | |
Return on tangible assets | 0.12 | 0.1 | 0.06 | 0.17 | 0.24 | |
Graham Net | -855.54 | -602.77 | -622.4 | -504.84 | -917.5 | |
Working capital | 3399.86B | 2072.18B | 3252.05B | 1270.48B | 2141.59B | |
Tangible asset value | 69.64B | -36.42B | 1014.85B | -511.67B | 2789.01B | |
Net current asset value | 1158.3B | 1685.34B | -875.6B | 2382.41B | 4690.82B | |
Invested capital | 0.69 | 0.84 | 0.58 | 0.16 | 0.27 | |
Average receivables | 285.01M | 1425.69B | 2425.81B | 1580.04B | 1001.76B | |
Average payables | 253.95B | 308.05B | 216.65B | 120.32B | 177.93B | |
Average inventory | 155.89M | 393.59M | 388.39M | 191.6M | 0 | |
Days sales outstanding | 0.05 | 294.96 | 282.12 | 95.36 | 69.03 | |
Days payables outstanding | 38.97 | 54.79 | 21.22 | 15.78 | 25.39 | |
Days of inventory on hand | 0.05 | 0.06 | 0.08 | 0 | 0 | |
Receivables turnover | 7.83K | 1.24 | 1.29 | 3.83 | 5.29 | |
Payables turnover | 9.37 | 6.66 | 17.2 | 23.13 | 14.37 | |
Inventory turnover | 6.67K | 5.68K | 4.38K | 0 | 0 | |
ROE | 0.12 | 0.11 | 0.05 | 0.08 | 0.09 | |
Capex per share | -323.87 | -248.44 | -190.9 | -215.04 | -612.94 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 267.53 | 234.85 | 294.52 | 286.7 | 3.28 | |
Net income per share | 48.56 | 34.02 | 46.61 | 44.19 | 79.28 | |
Operating cash flow per share | 49.1 | 34.02 | 46.61 | 43.73 | 119.36 | |
Free cash flow per share | -60.59 | -289.61 | -44.9 | -207.19 | -241.86 | |
Cash per share | -103.23 | 184.31 | 209.89 | 279.67 | 109.24 | |
Book value per share | 1.91K | 1.92K | 1.97K | 2.01K | 2.09K | |
Tangible book value per share | -232.62 | -513.35 | -548.88 | -647.84 | -951.11 | |
Share holders equity per share | 1.91K | 1.92K | 1.97K | 2.01K | 2.09K | |
Interest debt per share | 311.31 | 534.51 | 563.06 | 834.2 | 901.7 | |
Market cap | 10755.28B | 11898.1B | 9457.42B | 9349.72B | 8399.07B | |
Enterprise value | 11968.04B | 14408.32B | 11922.53B | 13253.43B | 12774.78B | |
P/E ratio | 10.19 | 16.09 | 9.33 | 9.73 | 4.87 | |
Price to sales ratio | 7.4 | 9.33 | 5.91 | 6 | 471 | |
POCF ratio | 40.33 | 64.38 | 37.33 | 39.33 | 12.94 | |
PFCF ratio | -32.68 | -7.56 | -38.75 | -8.3 | -6.39 | |
P/B Ratio | 1.04 | 1.14 | 0.88 | 0.86 | 0.74 | |
PTB ratio | 1.04 | 1.14 | 0.88 | 0.86 | 0.74 | |
EV to sales | 8.24 | 11.29 | 7.45 | 8.5 | 716.38 | |
Enterprise value over EBITDA | 35.76 | 43.91 | 31.33 | 33.98 | 21.3 | |
EV to operating cash flow | 44.87 | 77.96 | 47.06 | 55.75 | 19.69 | |
EV to free cash flow | -36.36 | -9.16 | -48.85 | -11.77 | -9.72 | |
Earnings yield | 0.02 | 0.02 | 0.03 | 0.03 | 0.05 | |
Free cash flow yield | -0.03 | -0.13 | -0.03 | -0.12 | -0.16 | |
Debt to equity | 0.16 | 0.27 | 0.28 | 0.41 | 0.42 | |
Debt to assets | 0.1 | 0.16 | 0.16 | 0.22 | 0.22 | |
Net debt to EBITDA | 3.62 | 7.65 | 6.48 | 10.01 | 7.29 | |
Current ratio | 0.52 | 0.47 | 0.49 | 0.68 | 0.49 | |
Interest coverage | 11.15 | 9.04 | 6.75 | 7.17 | 5.75 | |
Income quality | 1.01 | 1 | 1 | 0.99 | 1.51 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.04 | 0.01 | 0.01 | 0.36 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.76 | 0.79 | 0.79 | 0.78 | 0.82 | |
Capex to operating cash flow | -2.23 | -9.51 | -1.96 | -5.74 | -3.03 | |
Capex to revenue | -0.41 | -1.38 | -0.31 | -0.88 | -110.12 | |
Capex to depreciation | -205.59 | -22.96 | -8.94 | -35.77 | -43.47 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.44K | 1.21K | 1.44K | 1.41K | 1.93K | |
ROIC | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
Return on tangible assets | 0.07 | 0.05 | 0.06 | 0.05 | 0.11 | |
Graham Net | -987.15 | -917.77 | -957.21 | -1.07K | -1.36K | |
Working capital | 1935.55B | 2141.59B | 2187.09B | 1259.68B | 2099.49B | |
Tangible asset value | 1263.6B | 2789.01B | 2983.33B | 3521.6B | 5170.53B | |
Net current asset value | 3116.59B | 4690.82B | 4893.35B | 5415.42B | 6963.39B | |
Invested capital | 0.16 | 0.27 | 0.28 | 0.41 | 0.42 | |
Average receivables | 743.95B | 1166.04B | 841.84B | 913.06B | 1134.47B | |
Average payables | 170.97B | 220.42B | 362.34B | 411.44B | 343.75B | |
Average inventory | -743.95B | -743.95B | 0.5 | 1.27B | 86.73B | |
Days sales outstanding | 92.15 | 59.55 | 47.2 | 56.98 | 6.47K | |
Days payables outstanding | 18.61 | 22.17 | 38.85 | 24.75 | -59.43 | |
Days of inventory on hand | -121.4 | 0 | 0 | 0.2 | -26.98 | |
Receivables turnover | 0.98 | 1.51 | 1.91 | 1.58 | 0.01 | |
Payables turnover | 4.84 | 4.06 | 2.32 | 3.64 | -1.51 | |
Inventory turnover | -0.74 | 0 | 1186.01B | 446.21 | -3.34 | |
ROE | 0.03 | 0.02 | 0.02 | 0.02 | 0.04 | |
Capex per share | -109.69 | -323.63 | -91.51 | -250.93 | -361.23 |
CMNP.JK Frequently Asked Questions
What is PT Citra Marga Nusaphala Persada Tbk stock symbol ?
PT Citra Marga Nusaphala Persada Tbk is a ID stock and trading under the symbol CMNP.JK
What is PT Citra Marga Nusaphala Persada Tbk stock quote today ?
PT Citra Marga Nusaphala Persada Tbk stock price is $1580 today.
Is PT Citra Marga Nusaphala Persada Tbk stock public?
Yes, PT Citra Marga Nusaphala Persada Tbk is a publicly traded company.